This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bonfioli E, Berti L, Goss C, Muraro F, Burti L . BMC Psychiatry 2012; 12: 78.
Polymeropoulos MH, Licamele L, Volpi S, Mack K, Mitkus SN, Carstea ED et al Schizophr Res 2009; 108: 134–142.
Vik-Mo AO, Fernø J, Skrede S, Steen VM . BMC Pharmacol 2009; 9: 10–16.
Vik–Mo AO, Birkenaes AB, Fernø J, Jonsdottir H, Andreassen OA, Steen VM . Int J Neuropsychopharmacol 2008; 11: 679–684.
Zeng Y, Song JX, Shen XC . Phytother Res 2012; 26: 159–167.
Bei W-J, Guo J, Wu H-Y, Cao YJ . Evid Based Complement Altern Med 2012, Article number 970635: 1–10.
Altern Med Rev 2000; 5: 175–177.
Yin J, Xing H, Ye J . Metabolism 2008; 57: 712–717.
Curtis J, Newall H, Myles N, Shiers D, Samaras K . Acta Psychiatr Scand 2012; 126: 302–303.
Wei W, Zhao H, Wang A, Sui M, Liang K, Deng H et al Eur J Endocrinol 2012; 166: 99–105.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foley, D. A hypothesized mechanism for the cardiovascular risk associated with antipsychotic drug exposure and a potential preventive treatment. Mol Psychiatry 19, 12–13 (2014). https://doi.org/10.1038/mp.2012.175
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2012.175